Cargando…
The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment?
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567655/ https://www.ncbi.nlm.nih.gov/pubmed/33075529 http://dx.doi.org/10.1016/j.ijid.2020.10.032 |
_version_ | 1783596371603881984 |
---|---|
author | Dauby, Nicolas Bottieau, Emmanuel |
author_facet | Dauby, Nicolas Bottieau, Emmanuel |
author_sort | Dauby, Nicolas |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7567655 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75676552020-10-19 The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment? Dauby, Nicolas Bottieau, Emmanuel Int J Infect Dis Letter to the Editor The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021-02 2020-10-17 /pmc/articles/PMC7567655/ /pubmed/33075529 http://dx.doi.org/10.1016/j.ijid.2020.10.032 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Dauby, Nicolas Bottieau, Emmanuel The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment? |
title | The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment? |
title_full | The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment? |
title_fullStr | The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment? |
title_full_unstemmed | The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment? |
title_short | The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment? |
title_sort | unfinished story of hydroxychloroquine in covid-19: the right anti-inflammatory dose at the right moment? |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567655/ https://www.ncbi.nlm.nih.gov/pubmed/33075529 http://dx.doi.org/10.1016/j.ijid.2020.10.032 |
work_keys_str_mv | AT daubynicolas theunfinishedstoryofhydroxychloroquineincovid19therightantiinflammatorydoseattherightmoment AT bottieauemmanuel theunfinishedstoryofhydroxychloroquineincovid19therightantiinflammatorydoseattherightmoment AT daubynicolas unfinishedstoryofhydroxychloroquineincovid19therightantiinflammatorydoseattherightmoment AT bottieauemmanuel unfinishedstoryofhydroxychloroquineincovid19therightantiinflammatorydoseattherightmoment |